Weave
Founded Year
2022Stage
Series A | AliveTotal Raised
$31.6MLast Raised
$20M | 21 days agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+132 points in the past 30 days
About Weave
Weave is a company that provides regulatory automation management for the pharmaceutical and biotech sectors. Its offerings include a platform that automates regulatory document preparation and lifecycle management, aimed at improving drafting and compliance with global standards. It is used by pharma companies, biotechs, contract research organizations (CROs), and regulatory consultants. It was founded in 2022 and is based in New Haven, Connecticut.
Loading...
ESPs containing Weave
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The drug development strategy & compliance platforms market combines AI with regulatory automation and strategic decision-making tools to optimize drug development. These platforms leverage AI for regulatory documentation (including investigational new drug applications), compliance management, and portfolio optimization. Solutions include document automation, data integrity validation, knowledge …
Weave named as Challenger among 9 other companies, including Veeva Systems, IQVIA, and Certara.
Loading...
Research containing Weave
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Weave in 3 CB Insights research briefs, most recently on Sep 25, 2025.
Sep 25, 2025 report
Book of Scouting Reports: AI in Preclinical Development
May 23, 2025
The AI in drug R&D market map
Expert Collections containing Weave
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Weave is included in 2 Expert Collections, including Digital Health.
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Artificial Intelligence (AI)
20,628 items
Latest Weave News
Oct 20, 2025
Parexel , a clinical research organization (CRO) providing clinical and consulting solutions to the life sciences industry, has opened its new global headquarters in Raleigh’s North Hills Innovation District. “Opening our headquarters in the North Hills Innovation District in Raleigh marks an exciting chapter in Parexel’s growth,” said Peyton Howell, Chief Executive Officer at Parexel. “This modern, energy-efficient and highly sustainable space reflects how we are evolving the way we work — creating spaces that inspire innovation, flexibility and collaboration for our team as we support and accelerate the development of new therapies for patients.” The company relocated from its Durham location and now occupies two floors in the newly constructed, LEED-certified Tower 5. The building features an energy-efficient design, eco-friendly construction materials, water conservation systems, EV charging stations and easy accessibility to walking, biking and public transportation. Ongoing investment in NC Parexel has operated in North Carolina since 2014 and has around 1,100 employees across the state. The company continues regional investments in line with its commitments under the state's Job Development Investment Grant program. According to the company, the North Hills Innovation District headquarters is ideal for tapping into a workforce that understands the complexities of bringing new therapies to patients. “The area's prestigious universities supply skilled professionals in life sciences, data analytics, clinical research and regulatory affairs, while the local life sciences hub offers experienced personnel across drug development,” said Keri Mattox, the company’s Chief Business Officer. “This concentration of expertise, combined with the region's growing tech sector, creates a strong talent pool for our operations.” Emerging AI opportunities Mattox says that the state’s biotech and pharma landscape is poised for remarkable growth, with artificial intelligence emerging as a key driver. Parexel occupies two floors in the new LEED-certified Tower 5 at Raleigh's North Hills Innovation District. “Parexel is strategically positioned to leverage AI to accelerate drug development through our comprehensive clinical research services and strategic operating model,” she said. “The integration of artificial intelligence, particularly in clinical development, is revolutionizing how we identify targets, design trials and analyze data and outcomes – significantly reducing timelines and improving quality and success rates.” Advancing its AI strategy, Parexel recently entered into a partnership with Weave Bio to accelerate regulatory submission processes and the time to market for new therapies. Weave Bio is a pioneer in AI-native regulatory automation management solutions. As Weave’s CRO design partner, Parexel will maintain a period of exclusivity as the only CRO to use Weave’s AI templates designed in partnership with Parexel. “AI tools are only as strong as the people behind them. Human experts provide the context that guides our platform and help translate its findings into action,” said Lindsay Mateo, Chief Commercial Officer at Weave. “Through this partnership, Weave will tap into Parexel’s deep regulatory expertise to refine and expand our solutions across the drug development industry.”
Weave Frequently Asked Questions (FAQ)
When was Weave founded?
Weave was founded in 2022.
Where is Weave's headquarters?
Weave's headquarters is located at 467 Ellsworth Avenue, New Haven.
What is Weave's latest funding round?
Weave's latest funding round is Series A.
How much did Weave raise?
Weave raised a total of $31.6M.
Who are the investors of Weave?
Investors of Weave include Innovation Endeavors, Magnetic Ventures, TMV, U.S. Venture Partners, Serrado Capital and 5 more.
Who are Weave's competitors?
Competitors of Weave include Yseop and 4 more.
Loading...
Compare Weave to Competitors
Regxia is a scientific and regulatory consulting firm focused on the pharmaceutical and biotech industries. The company offers services including regulatory affairs support, dossier compilation and management, scientific and strategic consulting, clinical regulatory support, eCTD publishing, quality assurance systems, and pharmacovigilance and safety reporting. Regxia primarily serves small to mid-sized pharmaceutical and biotech companies, with knowledge of Canadian and US regulatory environments. It was founded in 2007 and is based in Vaughan, Ontario.
Narrativa works with generative AI technology. It focuses on content automation across sectors including life sciences, financial services, marketing and ecommerce, media, and entertainment. The company provides a generative AI content automation platform that helps enterprises produce content efficiently, automate regulatory documentation, and assist with processes for clinical trials, marketing campaigns, and media production. Narrativa's solutions aim to address industry-specific needs while maintaining data privacy, security, and compliance with regulatory standards. It was founded in 2015 and is based in Los Angeles, California.
Macrowing provides knowledge management and document management systems across various industries. It offers services for case management, document management, and enterprise content management, focusing on the creation, storage, and governance of structured and unstructured data. Its products aim to improve information security, optimize content management processes, and utilize artificial intelligence for data governance. It was formerly known as edoc2. It was founded in 2000 and is based in Shanghai, China.
Allucent provides drug development solutions within the pharmaceutical and biotechnology sectors. The company offers services such as clinical trial management, regulatory strategy consulting, and biostatistical programming, which assist small and mid-sized biotech companies in drug development. Allucent serves clients in the pharmaceutical and biotechnology industries, with expertise in therapeutic areas including oncology, neurology, and autoimmune disorders. Allucent was formerly known as CATO SMS. It was founded in 2014 and is based in Cary, North Carolina.
Scispot operates as a life sciences software company specializing inadvanced data infrastructure. The company offers an alternative to traditional electronic lab notebooks (ELN), laboratory information management systems (LIMS), and scientific data management systems (SDMS). Scispot automates research and development (R&D) and testing workflows, ensuring laboratory data is artificial intelligence (AI)-ready and enabling seamless integration with scientific applications and instruments. The approach allows life science companies to build their own digital ecosystem with custom data models and ontologies. It was founded in 2020 and is based in Kitchener, Canada.
Neuroute offers an AI platform that focuses on clinical development within the healthcare industry. The company offers an AI solution that assists in the design and execution of clinical studies by utilizing a database of historical studies and publications. Neuroute serves the clinical research sector, providing tools for the development of new clinical programs. Neuroute was formerly known as Neucruit. It was founded in 2019 and is based in London, United Kingdom.
Loading...